Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
CONTEXT: Among the genomic loci harboring potential candidate genes for prostatic cancer (PCa) is the 2q31-33 chromosomal region that harbors the gene encoding phosphodiesterase 11A (PDE11A). In addition, the combined cancer genome expression metaanalysis datasets included PDE11A among the top 1% down-regulated genes in PCa. OBJECTIVE: In the present study, we screened 50 unrelated PCa patients of Brazilian descent for PDE11A coding defects. DESIGN: The study consisted of PDE11A sequencing, in vitro functional assays, and immunostaining analysis. RESULTS: We identified eight different sequence alterations in 15 patients (30%): one stop-codon and seven missense mutations. Three of the variants (R202C, Y658C, and E840K) were novel, and the remaining five (Y727C, R804H, R867G, M878V, and R307X) have been associated with predisposition to adrenal or testicular tumors. The overall prevalence of PDE11A-inactivating sequence variants among PCa patients was significantly higher than in 287 healthy controls (0.16 vs. 0.051, respectively, P < 0.001, odds ratio 3.81, 95% confidence interval 1.86-7.81) and the R202C, Y658C, and E840K substitutions were not found in controls. All missense mutations led to decreased PDE11A activity in human embryonic kidney 293 and PC3M cells and immunostaining of PCa samples with sequence changes showed decreased PDE11A protein expression. CONCLUSION: Our data suggest that, like in the adrenal cortex and the testicular germ cells, PDE11A-inactivating genetic alterations may play a role in susceptibility to PCa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Horvath, A., Boikos, S., Giatzakis, C., Robinson-White, A., Groussin, L., Griffin, K. J., Stein, E., Levine, E., Delimpasi, G., Hsiao, H. P., et al. (2006) · Nature Genetics · doi:10.1038/ng1809 · Cited by 352
Self-citation
Cited by
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
Azevedo, M. F., Faucz, F. R., Bimpaki, E., Horvath, A., Levy, I., de Alexandre, R. B., Ahmad, F., Manganiello, V., & Stratakis, C. A. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1053 · Cited by 325
Self-citationCyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets
Ahmad, F., Murata, T., Shimizu, K., Degerman, E., Maurice, D., & Manganiello, V (2015) · Oral Diseases · doi:10.1111/odi.12275 · Cited by 184
“PDE11A mutations may also play a role in susceptibility to prostate cancer (Faucz et al, 2011) and testicular germ cell tumors (TGCT) (Horvath et al, 2009).”
BackgroundFaucz, F. R., Zilbermint, M., Lodish, M. B., Szarek, E., Trivellin, G., Sinaii, N., Berthon, A., Libé, R., Assié, G., Espiard, S., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4280 · Cited by 166
“The complete ARMC5-coding and surrounding intronic sequence of these patients and tumors was analyzed by classical bidirectional Sanger sequencing on germline DNA, as previously described (14), using the primers and conditions described in the Supplemental Table 1, published on the Endocrine Society’s Journals Online…”
MethodSelf-citationRothenbuhler, A., Horvath, A., Libé, R., Faucz, F. R., Fratticci, A., Raffin Sanson, M. L., Vezzosi, D., Azevedo, M., Levy, I., Almeida, M. Q., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04366.x · Cited by 96
Self-citationKamilaris, C. D. C., & Stratakis, C. A. (2018) · HORMONES · doi:10.1007/s42000-018-0072-y · Cited by 7
Self-citation
Metadata
- Authors
- Faucz, F. R., Horvath, A., Rothenbuhler, A., Almeida, M. Q., Libé, R., Raffin-Sanson, M.-L., Bertherat, J., Carraro, D. M., Soares, F. A., de Campos Molina, G., Campos, A. H., Alexandre, R. B., Bendhack, M. L., Nesterova, M., & Stratakis, C. A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2011-01
- Volume
- 96
- Issue
- 1
- Pages
- E135-E140
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2031750528
- Cited by
- 46
- References
- 1
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer. https://app.cochat.ai/papers/10.1210/jc.2010-1655
- The paper
- Faucz, F. R., Horvath, A., Rothenbuhler, A., Almeida, M. Q., Libé, R., Raffin-Sanson, M.-L., Bertherat, J., Carraro, D. M., Soares, F. A., de Campos Molina, G., Campos, A. H., Alexandre, R. B., Bendhack, M. L., Nesterova, M., & Stratakis, C. A. (2011). Phosphodiesterase 11A (PDE11A) Genetic Variants May Increase Susceptibility to Prostatic Cancer. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2010-1655
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.